Bridget A. Scoville, Pharm.D., BCPS
- Critical Care Nephrology Fellowship, University of Michigan College of Pharmacy, Ann Arbor, MI
- PGY-1 Pharmacy Practice Residency, University of Florida Health at Jacksonville, Jacksonville, FL
- Doctor of Pharmacy, Drake University College of Pharmacy and Health Sciences, Des Moines, IA
- Bachelor of Science in Neuroscience, Drake University, Des Moines, IA
Courses Taught at ACPHS
- Integrated Problem Solving Workshop 5
- Integrated Problem Solving Workshop 6
- Nephrology Patient Care Elective
- Advanced Nephrology Elective
- Advance Pharmacy Practice Experience – Internal Medicine
Dr. Scoville’s research interests include medication removal pharmacokinetics during different modalities of renal replacement therapy and in medication dosing in patients with either acute kidney injury or chronic kidney disease.
American Society of Nephrology Kidney Week Professional Development Seminar Travel Award (2012)
Scoville BA, Mueller BA. Renal Replacement Therapy Influence on Pharmacotherapy in Critically Ill Patients with Acute Kidney Injury. Am J Kidney Dis. 2013;61(3):490-500.
Mueller BA, Jasiak KD, Thiel SR, Stevenson JM, Vilay AM, Scoville BA, Churchwell MD, Pasko DA, Perkins N. Vibration Enhances Clearance of Solutes with Varying Molecular Weights during in vitro Hemodialysis. ASAIO J. 2013;53(2):140-144.
Posters and PresentationS of Original Research
Scoville BA, Vulaj V, Annich G, Mueller BA, Wagner DS. Intravenous Acetaminophen Clearance During In Vitro Continuous Renal Replacement Therapy. [Abstract] Crit Care Med. 2013:906.
Mueller BA, Scoville BA, Eyler EF, Heung M, Segal JH. Pharmacokinetics of Single Dose Oral Ranolazine in Subjects Receiving Maintenance Hemodialysis. [Abstract] J Am Soc Nephrol. 2012:559A.